Virometix, the privately held Swiss biotechnology company who is developing a new generation of fully synthetic vaccines and immunotherapeutic drugs for the prevention and treatment of infectious diseases and cancer.
Virometix AG
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttps://www.virometix.com
Founded
Disease Focus
Development Stage
STOCK CODENon Listed
AddressWagisstrasse 14CH-8952SchlierenSwitzerland
Wagisstrasse 14CH-8952
Schlieren
Switzerland
Contact Number+41 43 433 86 60
+41 43 433 86 60
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]